Literature DB >> 24492002

VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damage.

Inmaculada López-Sánchez1, Alberto Valbuena1, Marta Vázquez-Cedeira2, Jyoti Khadake3, Marta Sanz-García1, Alejandro Carrillo-Jiménez1, Pedro A Lazo4.   

Abstract

DNA damage immediate cellular response requires the activation of p53 by kinases. We found that p53 forms a basal stable complex with VRK1, a Ser-Thr kinase that responds to UV-induced DNA damage by specifically phosphorylating p53. This interaction takes place through the p53 DNA binding domain, and frequent DNA-contact mutants of p53, such as R273H, R248H or R280K, do not disrupt the complex. UV-induced DNA damage activates VRK1, and is accompanied by phosphorylation of p53 at Thr-18 before it accumulates. We propose that the VRK1-p53 basal complex is an early-warning system for immediate cellular responses to DNA damage.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA damage; Interaction; Phosphorylation; Vaccinia-related kinase 1; p53

Mesh:

Substances:

Year:  2014        PMID: 24492002     DOI: 10.1016/j.febslet.2014.01.040

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

Review 1.  p53 regulation upon genotoxic stress: intricacies and complexities.

Authors:  Rajni Kumari; Saishruti Kohli; Sanjeev Das
Journal:  Mol Cell Oncol       Date:  2014-12-23

2.  The Balance between p53 Isoforms Modulates the Efficiency of HIV-1 Infection in Macrophages.

Authors:  Yann Breton; Corinne Barat; Michel J Tremblay
Journal:  J Virol       Date:  2021-08-11       Impact factor: 5.103

3.  Identification of key gene contributing to vitiligo by immune infiltration.

Authors:  Hefang Xiao; Yonghui Dong; Likang Xiao; Xiaming Liang; Jia Zheng
Journal:  Int J Clin Exp Pathol       Date:  2022-04-15

4.  VRK1 regulates Cajal body dynamics and protects coilin from proteasomal degradation in cell cycle.

Authors:  Lara Cantarero; Marta Sanz-García; Hadar Vinograd-Byk; Paul Renbaum; Ephrat Levy-Lahad; Pedro A Lazo
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

5.  Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition.

Authors:  Namgyu Lee; Jung-Hee Kwon; Young Bae Kim; Seong-Hoon Kim; Sung Jin Park; Weiguang Xu; Hoe-Yune Jung; Kyong-Tai Kim; Hee Jung Wang; Kwan Yong Choi
Journal:  Oncotarget       Date:  2015-10-06

6.  VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage.

Authors:  Marcella Salzano; Marta Sanz-García; Diana M Monsalve; David S Moura; Pedro A Lazo
Journal:  Epigenetics       Date:  2015-04-29       Impact factor: 4.528

7.  Comparative Interactomes of VRK1 and VRK3 with Their Distinct Roles in the Cell Cycle of Liver Cancer.

Authors:  Namgyu Lee; Dae-Kyum Kim; Seung Hyun Han; Hye Guk Ryu; Sung Jin Park; Kyong-Tai Kim; Kwan Yong Choi
Journal:  Mol Cells       Date:  2017-09-20       Impact factor: 5.034

8.  DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells.

Authors:  Rebeca Carrión-Marchante; Valerio Frezza; Ana Salgado-Figueroa; M Isabel Pérez-Morgado; M Elena Martín; Víctor M González
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-17

9.  Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells.

Authors:  Seong-Hoon Kim; Hye Guk Ryu; Juhyun Lee; Joon Shin; Amaravadhi Harikishore; Hoe-Yune Jung; Hoe-Youn Jung; Ye Seul Kim; Ha-Na Lyu; Eunji Oh; Nam-In Baek; Kwan-Yong Choi; Ho Sup Yoon; Kyong-Tai Kim
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

10.  Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiation.

Authors:  David S Moura; Isabel F Fernández; Gema Marín-Royo; Inmaculada López-Sánchez; Elena Martín-Doncel; Francisco M Vega; Pedro A Lazo
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.